Revolutionary Point-of-Care Test for Toxoplasmosis Detection

An innovative point-of-care test is transforming the landscape of toxoplasmosis screening. The groundbreaking test, developed by LDBIO Diagnostics, provides rapid and accurate results for detecting infections with Toxoplasma gondii. This new diagnostic tool offers a quick turnaround time, delivering results within 30 minutes from a finger-prick or within an hour from a small blood sample. The test not only identifies infections but can also detect false positives from other commercial diagnostic tests, offering fast reassurance to pregnant women and their healthcare providers.

Utilizing this cutting-edge approach, led by toxoplasmosis specialist Rima McLeod, MD, from the University of Chicago, pregnant women can be screened monthly for Toxoplasma infections, starting early in pregnancy. This proactive monitoring can prevent infections in babies and address the issue of false positives from existing tests, providing cost-effective solutions and peace of mind to expecting mothers and their doctors.